Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
      QxMD      Google Scholar   
Citation:
N Engl J Med vol 379 (26) 2517-28
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
8
Parents:
2985  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
Older Adult    
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA189823, U10CA180790, U10CA180833, U10CA180836, U10CA180850, U10CA180857, U10CA180867, P30CA033572, UG1CA189858, U10CA180820, U10CA180888, U24CA196171, K23CA178183, R01CA197870, R35 CA197734  
Corr. Author:
 
Authors:
                                                               
Networks:
IL017, IL040, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, NY167, OH070, SCOR   
Study
Alliance-A041202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: